Sector Teams More
| Consumer | Financials |
| Healthcare | Industrials |
| Investment Companies & Trusts | Property |
| Resources - Mining | Resources - Oil & Gas |
| Technology |
Latest companies under coverage
| Gasol | TiGenix |
| Lo-Q | Secure Trust Bank |
| The Diverse Income Trust | Transgene |
| BioInvent | South American Silver Corp |
| EnWave Corporation | MediGene |
Companies
Zanaga Iron Ore Company
Mining
Zanaga Iron Ore Company manages its 50% less one share in the Zanaga iron ore project located in Congo Brazzaville. The project has JORC resources of 4.3bn tonnes at 33% Fe, is expected to deliver first production in 2017 and is managed by Xstrata.
Zeltia
Pharmaceutical & Healthcare
Zeltia is a Spanish biopharma group with a core focus on the development of marine-based drugs for cancer and CNS disease. The group also has subsidiaries active in diagnostic kits, RNAi technology and consumer chemicals.
Zetar
Food & Drink
Zetar is a leading manufacturer of confectionery and natural snacks, with a reputation for quality and product innovation. It has strong relationships with all major UK food retailers and with many global media brand licensors.
Zotefoams
Basic Industries
Zotefoams is a manufacturer of polyolefin and high-performance polymers foams. Its high value added products are used in a range of markets, including aerospace, automotive and construction.
Zealand Pharma
Pharmaceutical & Healthcare
Zealand Pharma is a diabetes play with a solid phase III product about to report huge amounts of clinical data. The November IPO raised DKK320m net at DKK86/share. There are seven GetGoal trials reporting in 2011 with two already announced. A Lantus combination study reports in H112, while ZP2929 enters Phase II in 2011.
Zenergy Power
Alternative Energy
Zenergy Power is a specialist manufacturer and developer of products using high-temperature superconductor (HTS) technology. HTS materials have no electrical resistance and Zenergy's products aim to improve the efficiency and cost of industrial processes, often replacing copper components.
Ziopharm Oncology
Pharmaceutical & Healthcare
Ziopharm Oncology is focused on the development of less-toxic versions of known small molecule anticancers and a highly novel synthetic biology platform. Its lead programmes are palifosfamide (Phase III), darinaparsin (Phase II/III) and indibulin (Phase I/II).
